Bruce Spohler
Analyst · JMP Securities. Your line is now open
Thank you, Rich. I’d like to begin by providing an update on the credit quality of our portfolio. The financial health of our portfolio companies remained sound. With the trends of continued modest growth, as well as deleveraging through strong free cash flow, which continued through the fourth quarter. At 12/31, the fair value weighted average leverage level through our security was 5.3 times down from 5.5 times at the end of the prior year. Also at year end, the fair value weighted average interest coverage for our portfolio of companies was 2.7 times covered. At the end of 2015, our portfolio had a weighted average EBITDA of over $80 million. On a fair value basis, revenues and EBITDA for the portfolio of companies increased 7% and 15% respectively for 2015. The weighted average investment risk waiting of our portfolio was just over 2, based on our 1 to 4 risk rating scale with one representing the least amount of risk. Measured at fair value, our 99.9% of our portfolio was performing at December 15. On a cost basis, our one investment on non-accrual accounted for 63 bps of the portfolio. Excluding this one 2007 legacy asset, our portfolio continues to perform well. Furthermore, as Michael mentioned, we continue to have no direct exposure to the oil and gas or commodity sectors. In the fourth quarter, our NAV decline of 3.4% was primarily due to technical mark-to-market write-downs resulting from the broad sell off in the liquid credit markets. We expect to fully recoup this value when our loans are repaid. Now I’d like to provide some color on the composition of our comprehensive investment portfolio; this includes Crystal Financials full portfolio of asset based loans, as well as our ownership of the Unitranche Loans in our SSLP joint venture. Thanks to our focused origination efforts, over the last couple of years we’ve essentially completed the rotation of our existing portfolio into senior secure floating rate investments. At fiscal year-end, our $1.5 billion comprehensive investment portfolio included 76 borrowers across 46 industries with neither direct energy nor commodities on that list. When measured at fair value, roughly 93% of our portfolio of consistent senior secured loans. The remaining 7% of the portfolio was comprised of 4.5% subordinated debt and 2.5% equity. At December 15, approximately 92% of our income producing portfolio was floating rate when measured at fair value. Before I turn to specific portfolio activity, let me give you a brief update on each of our strategic initiatives. During the fourth quarter, we seeded the SSLP with four investments; two of which we sold from our balance sheet into joint venture and two of which we closed directly into the joint venture. At quarter-end, our ownership interest totaled just over $80 million of the approximately $92 million of portfolio fair value. The four loans in the SSLP had a weighted average yield of 8.5%. The JV is currently unlevered. We intend to close the credit facility or the SSLP in the second quarter and lever the vehicle approximately 1.5 to 2 times when its fully ramped, which we expect will result in a low to mid-teens ROE at full ramp. Over the coming quarters, we expect our momentum with the strategic initiative to increase. We have over $1.5 billion of available capital collectively committed to the strategy by Solar-PIMCO partnership with a competitive advantage in the current market. With the benefit of hindsight, we are happy with our decision to take a patient approach to deploying our capital into this strategy. We expect the current market dislocation to enable us to support to source Unitranche Loans with higher yields and better terms that had been possible last year. In fact, we view Unitranche and First Lien loans as providing the best risk reward characteristic in the current market environment. Now, let me turn to Crystal. Crystal Financial, our stretch first lien ABL lending platform at December 31 had a diversified portfolio consisting of approximately $465 million of funded senior secured loans across 26 borrowers with an average exposure of just under $18 million. During 2015, Crystal funded new loans of approximately $225 million and experienced repayments totaling approximately $231 million. As a reminder all of Crystal investments are floating rate senior secured loans. For Q4, Crystal paid Solar a cash dividend of $7.9 million, representing an 11.5% annualized cash on cash yield, this is consistent with the prior quarter. Crystal’s net debt to equity ratio was 0.77 times at year-end. Now let me turn to our life science portfolio. For fourth quarter our life science portfolio totaled approximately $119 million of first lien senior secured loans across 9 borrowers with an average investment of $13 million and an average all in yield excluding potential success fees and warrants of just over 10.5%. During 2015, the Life Science lending platform originated $104 million of investments and had approximately $45 million of repayments. The blended IRR on all realized Life Science investments to date exceeds 20%. Our investment thesis continues to focus on building a diversified portfolio of senior secured loans and having a very modest debt to equity ratio, along with significant enterprise value protection. Ultimately, we’d like to see our Life Science portfolio grow to approximately $200 million to $250 million and we are well on the way to do that this year. Now I’d like to turn to our specific fourth quarter portfolio activity. The restrains that we demonstrated in deploying capital during the frenzy of late 2012 through 2015, while we developed our strategic initiatives is finally paying off. During the fourth quarter, including the activity with the SSLP that is attributable to our 87.5% ownership, Solar originated approximately $162 million of senior secured floating rate loans across 11 portfolio of companies. Investments prepaid during the quarter, totaled approximately $27.5 million, which resulted in net originations of approximately $135 million for the quarter. Thus far, in the first quarter we have visibility of $30 million of repay, and we expect repayment activity to be muted during the remainder of this year. For the full year 2015, we originated approximately $478 million of new senior secured floating rate loans. During the year, we repaid or sold $145 million of investments, which compares to $655 million of repayment in 2013 and $626 million of repayment in 2014. Our strong origination results coupled with repayments far below 2013 and 2014 average resulted in net portfolio growth of $333 million last year. I will now provide the highlights of our fourth quarter activity. We played a significant role in the underwriting of $215 million of senior secured first lien term loan to finance the Huntsman Family acquisition of Am Pac’s specialty chemicals. Of the total investment, Solar and the SSLP funded $50 million with Voya and our PIMCO SMA purchasing the loan as well. The company is the only North American producer of certain rock grade chemicals used in the US Department of Defense Programs, NASA and the US Air Force Satellite launches, in addition to NASA’s space exploration programs. Closing leverage was 4.4 times and our yield exceeds 8.2%. We also originated a $35 million investment in the unitranche facility, at PSKW. Owned by Genstar Capital, the company is a leading provider of co-pay assistance programs for branded prescription drugs. Of the total investment, Solar and the SSLP funded $35 million. Voya also participated directly alongside of us. Leverage store loan approximated 5.8 times and the all in yield is over 9.5%. During Q4, we sold into the SSLP our $20 million first lien term loan for SSLP partners. On balance sheet at Solar, we continue to hold $30 million of the company’s second lien term loan, which was repriced upward during Q4. I’ll touch on that momentarily. We also sold into the SSLP in Q4 our $15 million first lien term loan issued by [indiscernible]. During the fourth quarter, our $30 million second lien investment in US Anesthesia repriced from L800 to L plus 925, in conjunction with the financing to support a strategic add on acquisition. Since our initial investment in the company’s loans in September 2014, USAF has experienced significant growth both organically and through acquisitions resulting in pro forma EBITDA today of approximately $159 million alongside significant deleveraging. The all in yield on our second lien investment is now just under 11%. In addition, we invested $32 million in the second lien term loan to five med management, which is a leading provider of outsourced Anesthesia services to hospitals and other medical providers. Solar and Aries Capital clubbed together to provide full second lien term loan to the company, which is owned by Ontario Teachers, the all-in yield on the loan just under 11%. Lastly, we made a $9 million incremental in TierPoint, a leading provider of infrastructure solutions, which brought out full exposure to TierPoint up to $34 million. The incremental loans supported the company’s acquisition of Windstream Hosted Solutions. This acquisition strategically increased the company’s scale, extends its national footprint and enhances its product suite. On a pro forma basis, the company received approximately $120 million. In conjunction with our add on investment, our existing investment was repriced upward by 100 basis points to L875, and the leverage levels were reduced. Our all in yield is now just over 10.25%. The repricing of our loans to both TierPoint and US Anesthesia speaks to the current trend of market terms coming our way, both in terms of higher yields, as well as larger more stable companies needing our capital because their access to the liquid new issue markets has become limited. During the quarter, we took advantage of headline noise in two portfolio companies to increase our holdings via the secondary market. We purchased just under $7 million of Global Tel Link, GTL, first lien loan at a weighted average price of approximately 78% at par, and a weighted average yield of 11 and two thirds, 11.67. Global Tel provides telecom services to FCC. Global Tel provides telecom services to the US Prison population. In late 2015, the FCC passed the vote and drafted pay order, capping inter-state and intra-state call rates and fees, in response Global Tel is seeking a stay – and seeking to appeal the order. The industry previously experienced similar regulatory challenges with mutual positive outcomes for the company and the credit. Currently, senior leverage is approximately 3 times and total leverage is approximately 4.3 times. Based on our current understanding, we believe the first lien term loan, which repurchased in Q4 at deep discounts will be repaid at par. Since the end of the quarter, the first lien term loan has been quoted up and is currently in the 80 to 83 area following the release of the company’s strong 2016 budget. This compares to our most recent purchase of the loan at 73. Again, we believe we will be repaid in full on Global Tel Link. As Michael mentioned we have been patiently waiting for the credit cycle to turn our way. And now is the time for us to grow our portfolio via more attractive investments. We believe that first lien loans grew our Life Science platform, our Crystal platform and SSLP joint venture offer the best risk reward characteristics in today’s credit environment. Our Life Science pipeline is robust. In addition with PIMCO and Voya, our collective dry powder gives us a competitive advantage as we seek to ramp SSLP. Now I’d like to turn the call back over to Michael.